MRVL News and Press, Marvell Technology Inc. From 03/17/24

2024-03-17 12:00:00 ET Artificial intelligence (AI) has become the hottest investment theme, captivating the minds of both seasoned investors and newbies alike. This is not surprising, considering multiple research firms expect the AI market to be worth more than $1 trillion by 2030. Wi...

2024-03-17 06:40:00 ET Marvell Technology 's (NASDAQ: MRVL) red-hot stock market rally came to a grinding halt following the release of the company's fiscal 2024 fourth-quarter results (for the three months ended Feb. 3, 2024) as its guidance turned out to be significantly below Wal...

2024-03-16 09:22:25 ET Summary Hewlett Packard Enterprise faces challenges in FY24 as customers are slow to implementing server infrastructure purchased in FY23, impacting revenue growth. Bottlenecks resulting from high demand for Nvidia accelerators may not resolve until late 202...

2024-03-15 17:00:00 ET Tech companies facilitating artificial intelligence technology (AI) have risen to prominence over the past year. Among these is Marvell Technology (NASDAQ: MRVL) , which saw its stock hit a 52-week high of $85.76 on March 7, just before the company announced e...

2024-03-14 10:47:01 ET Marvell Technology Group Ltd (MRVL) MRVL is trading DOWN for the last 4 days, and it at trading at $66.44 with volume of 5,352,740 and a one day change of $-1.19 (-1.76%). Marvell Technology Group Ltd has a 52-week low of 36.64 and a 52-week high of $85.76. Th...

2024-03-12 16:10:27 ET Summary Marvell Technology's Q4'24 earnings report showed growth in the data center segment but declines in enterprise networking, carrier infrastructure, consumer, and automotive/industrials. The company expects continued strength in the data center segment...

2024-03-12 12:42:00 ET Marvell Technology (NASDAQ: MRVL) stock had a marvelous start to 2024, rising 41% until ... well, until it delivered a big disappointment on Friday. In its earnings report for the fourth quarter of its fiscal 2024, Marvell merely met Wall Street's targets...

Calgary, Alberta--(Newsfile Corp. - March 12, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), today reported promising interim results from its study on MB-204, a new treatment...

2024-03-11 10:00:02 ET Chris Caso from Wolfe Research issued a price target of $90.00 for MRVL on 2024-03-11 07:20:00. The adjusted price target was set to $90.00. At the time of the announcement, MRVL was trading at $75.42. The overall price target consensus is at $76.2...

2024-03-11 09:30:03 ET Wolfe Research analyst issues OUTPERFORM recommendation for MRVL on March 11, 2024 07:20AM ET. The previous analyst recommendation was Outperform. MRVL was trading at $75.42 at issue of the analyst recommendation. The overall analyst consensus : BU...